These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27226307)

  • 1. Growth hormone is permissive for neoplastic colon growth.
    Chesnokova V; Zonis S; Zhou C; Recouvreux MV; Ben-Shlomo A; Araki T; Barrett R; Workman M; Wawrowsky K; Ljubimov VA; Uhart M; Melmed S
    Proc Natl Acad Sci U S A; 2016 Jun; 113(23):E3250-9. PubMed ID: 27226307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous disruption of the PTEN promotes intestinal neoplasia in APCmin/+ mouse: roles of osteopontin.
    Shao J; Washington MK; Saxena R; Sheng H
    Carcinogenesis; 2007 Dec; 28(12):2476-83. PubMed ID: 17693663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA-targeted inhibition of growth hormone receptor in human colon cancer SW480 cells.
    Zhou D; Yang J; Huang WD; Wang J; Zhang Q
    World J Gastroenterol; 2013 Nov; 19(44):8108-13. PubMed ID: 24307807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout mice.
    Takahara K; Ibuki N; Ghaffari M; Tearle H; Ong CJ; Azuma H; Gleave ME; Pollak M; Cox ME
    Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):239-47. PubMed ID: 23689346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist.
    Iida K; Del Rincon JP; Kim DS; Itoh E; Nass R; Coschigano KT; Kopchick JJ; Thorner MO
    Endocrinology; 2004 Apr; 145(4):1564-70. PubMed ID: 14726438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
    Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
    Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microenvironment influence on human colon adenocarcinoma phenotypes and matrix metalloproteinase-2, p53 and β-catenin tumor expressions from identical monoclonal cell tumor in the orthotopic model in athymic nude rats.
    Priolli DG; Abrantes AM; Neves S; Gonçalves AC; Lopes CO; Martinez NP; Cardinalli IA; Ribeiro AB; Botelho MF
    Scand J Gastroenterol; 2014 Mar; 49(3):309-16. PubMed ID: 24325610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon epithelial cell differentiation is inhibited by constitutive c-myb expression or mutant APC plus activated RAS.
    Ramsay RG; Ciznadija D; Sicurella C; Reyes N; Mitchelhill K; Darcy PK; D'Abaco G; Mantamadiotis T
    DNA Cell Biol; 2005 Jan; 24(1):21-9. PubMed ID: 15684716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced colonic apoptosis in mice overexpressing bovine growth hormone occurs through changes in several kinase pathways.
    Bogazzi F; Ultimieri F; Raggi F; Russo D; Lombardi M; Cosci C; Brogioni S; Gasperi M; Bartalena L; Martino E
    Growth Horm IGF Res; 2009 Oct; 19(5):432-41. PubMed ID: 19230732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.
    Kineman RD; Teixeira LT; Amargo GV; Coschigano KT; Kopchick JJ; Frohman LA
    Endocrinology; 2001 Sep; 142(9):3764-73. PubMed ID: 11517152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for growth hormone (GH) autoregulation in pituitary somatotrophs in GH antagonist-transgenic mice and GH receptor-deficient mice.
    Asa SL; Coschigano KT; Bellush L; Kopchick JJ; Ezzat S
    Am J Pathol; 2000 Mar; 156(3):1009-15. PubMed ID: 10702416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone is necessary for the p53-mediated, obesity-induced insulin resistance in male C57BL/6J x CBA mice.
    Bogazzi F; Raggi F; Russo D; Bohlooly-Y M; Sardella C; Urbani C; Lombardi M; Manetti L; Lupi I; Tornell J; Martino E
    Endocrinology; 2013 Nov; 154(11):4226-36. PubMed ID: 23913444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone is a cellular senescence target in pituitary and nonpituitary cells.
    Chesnokova V; Zhou C; Ben-Shlomo A; Zonis S; Tani Y; Ren SG; Melmed S
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3331-9. PubMed ID: 23940366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly.
    Bianchi A; Giustina A; Cimino V; Pola R; Angelini F; Pontecorvi A; De Marinis L
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2015-22. PubMed ID: 19336510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice.
    Michaylira CZ; Ramocki NM; Simmons JG; Tanner CK; McNaughton KK; Woosley JT; Greenhalgh CJ; Lund PK
    Endocrinology; 2006 Apr; 147(4):1632-41. PubMed ID: 16410303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
    Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
    Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
    Kohler S; Tschopp O; Sze L; Neidert M; Bernays RL; Spanaus KS; Wiesli P; Schmid C
    Gen Comp Endocrinol; 2013 Jul; 188():282-7. PubMed ID: 23648743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.